Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2010 May;21 Suppl 5:v23-30. doi: 10.1093/annonc/mdq244.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • CA-125 Antigen / blood
  • Carcinoma / classification
  • Carcinoma / diagnosis*
  • Carcinoma / pathology
  • Europe / epidemiology
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Membrane Proteins / blood
  • Meta-Analysis as Topic
  • Neoplasm Staging
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Secondary Prevention
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • CA-125 Antigen
  • MUC16 protein, human
  • Membrane Proteins